

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histamine transport (GO:0051608) | 9.92267378 |
| 2 | meiotic chromosome segregation (GO:0045132) | 9.86319010 |
| 3 | tooth mineralization (GO:0034505) | 7.87567049 |
| 4 | resolution of meiotic recombination intermediates (GO:0000712) | 7.83848314 |
| 5 | fatty acid elongation (GO:0030497) | 7.66465719 |
| 6 | drug transmembrane transport (GO:0006855) | 7.30678073 |
| 7 | quaternary ammonium group transport (GO:0015697) | 7.02273250 |
| 8 | neurotransmitter biosynthetic process (GO:0042136) | 6.98649886 |
| 9 | organic cation transport (GO:0015695) | 6.97467892 |
| 10 | regulation of immune response to tumor cell (GO:0002837) | 6.28871088 |
| 11 | regulation of response to tumor cell (GO:0002834) | 6.28871088 |
| 12 | positive regulation of response to tumor cell (GO:0002836) | 6.28871088 |
| 13 | positive regulation of immune response to tumor cell (GO:0002839) | 6.28871088 |
| 14 | positive regulation of meiosis (GO:0045836) | 6.20718422 |
| 15 | bone trabecula formation (GO:0060346) | 5.94744274 |
| 16 | exogenous drug catabolic process (GO:0042738) | 5.94331679 |
| 17 | neurotransmitter metabolic process (GO:0042133) | 5.79504001 |
| 18 | positive regulation of meiotic cell cycle (GO:0051446) | 5.75136131 |
| 19 | synaptonemal complex assembly (GO:0007130) | 5.63048882 |
| 20 | azole transport (GO:0045117) | 5.45265566 |
| 21 | synaptonemal complex organization (GO:0070193) | 5.15198930 |
| 22 | positive regulation of hair follicle development (GO:0051798) | 5.02784015 |
| 23 | positive regulation of hair cycle (GO:0042635) | 5.02784015 |
| 24 | drug transport (GO:0015893) | 5.00415114 |
| 25 | histone H3-K36 demethylation (GO:0070544) | 4.99912498 |
| 26 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.81736729 |
| 27 | histone-serine phosphorylation (GO:0035404) | 4.78972196 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 4.75627818 |
| 29 | positive regulation of protein homodimerization activity (GO:0090073) | 4.66975511 |
| 30 | rRNA catabolic process (GO:0016075) | 4.58788441 |
| 31 | drug catabolic process (GO:0042737) | 4.53130810 |
| 32 | reciprocal meiotic recombination (GO:0007131) | 4.44050473 |
| 33 | reciprocal DNA recombination (GO:0035825) | 4.44050473 |
| 34 | regulation of meiosis I (GO:0060631) | 4.43259237 |
| 35 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.27829342 |
| 36 | thrombin receptor signaling pathway (GO:0070493) | 4.25940985 |
| 37 | negative regulation of telomere maintenance (GO:0032205) | 4.22063199 |
| 38 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.18851999 |
| 39 | protein neddylation (GO:0045116) | 4.15573219 |
| 40 | chromosome organization involved in meiosis (GO:0070192) | 4.14073564 |
| 41 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.10282986 |
| 42 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.07178648 |
| 43 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.01835301 |
| 44 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.98785391 |
| 45 | cranial suture morphogenesis (GO:0060363) | 3.96330734 |
| 46 | * detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.95051083 |
| 47 | endothelium development (GO:0003158) | 3.94438955 |
| 48 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.88475762 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 3.83113118 |
| 50 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.82948054 |
| 51 | L-phenylalanine catabolic process (GO:0006559) | 3.64576455 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.64576455 |
| 53 | wound healing, spreading of epidermal cells (GO:0035313) | 3.64069452 |
| 54 | carnitine shuttle (GO:0006853) | 3.58092611 |
| 55 | histone phosphorylation (GO:0016572) | 3.54263172 |
| 56 | tyrosine metabolic process (GO:0006570) | 3.46293018 |
| 57 | behavioral response to nicotine (GO:0035095) | 3.42894989 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41945039 |
| 59 | protein K6-linked ubiquitination (GO:0085020) | 3.37907611 |
| 60 | arginine catabolic process (GO:0006527) | 3.30896887 |
| 61 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27801976 |
| 62 | regulation of memory T cell differentiation (GO:0043380) | 3.21712953 |
| 63 | synapsis (GO:0007129) | 3.21126041 |
| 64 | negative regulation by host of viral transcription (GO:0043922) | 3.06606679 |
| 65 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.05346766 |
| 66 | L-phenylalanine metabolic process (GO:0006558) | 3.05282105 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.05282105 |
| 68 | regulation of activation of Janus kinase activity (GO:0010533) | 3.04653421 |
| 69 | regulation of hair follicle development (GO:0051797) | 3.04550806 |
| 70 | polyamine biosynthetic process (GO:0006596) | 3.02404668 |
| 71 | secretory granule organization (GO:0033363) | 2.95512000 |
| 72 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.95197703 |
| 73 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.93244937 |
| 74 | * detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.84574432 |
| 75 | C4-dicarboxylate transport (GO:0015740) | 2.84094547 |
| 76 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.83762013 |
| 77 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82116667 |
| 78 | aromatic amino acid family catabolic process (GO:0009074) | 2.81965650 |
| 79 | negative regulation of epidermis development (GO:0045683) | 2.79873669 |
| 80 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.77452683 |
| 81 | regulation of energy homeostasis (GO:2000505) | 2.75785699 |
| 82 | rRNA methylation (GO:0031167) | 2.73957131 |
| 83 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.73830449 |
| 84 | positive regulation of viral genome replication (GO:0045070) | 2.70619587 |
| 85 | trabecula formation (GO:0060343) | 2.70398759 |
| 86 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.69309631 |
| 87 | regulation of meiosis (GO:0040020) | 2.68607728 |
| 88 | platelet formation (GO:0030220) | 2.68428109 |
| 89 | proline biosynthetic process (GO:0006561) | 2.68180639 |
| 90 | carnitine transmembrane transport (GO:1902603) | 2.66587582 |
| 91 | outflow tract septum morphogenesis (GO:0003148) | 2.65599623 |
| 92 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.65585724 |
| 93 | regulation of mast cell activation (GO:0033003) | 2.62891475 |
| 94 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.60491832 |
| 95 | lysosome localization (GO:0032418) | 2.59926787 |
| 96 | platelet aggregation (GO:0070527) | 2.59107116 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.58327939 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.58327939 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56096133 |
| 100 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.55994390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.63855053 |
| 2 | IRF1_19129219_ChIP-ChIP_H3396_Human | 3.82614240 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.58788343 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.55757501 |
| 5 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76306545 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 2.68465517 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65335168 |
| 8 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.41024352 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.40557389 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36975389 |
| 11 | NANOG_20526341_ChIP-Seq_ESCs_Human | 2.26037434 |
| 12 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.23683462 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20564850 |
| 14 | GATA2_19941826_ChIP-Seq_K562_Human | 2.08021414 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00771483 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98850763 |
| 17 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.95964603 |
| 18 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.88785327 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.81288070 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80065614 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75877470 |
| 22 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75372724 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74441460 |
| 24 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62325194 |
| 25 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56582847 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56239291 |
| 27 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.55470007 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53450737 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53220067 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52785356 |
| 31 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.51640009 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50227986 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48339012 |
| 34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47795830 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47253471 |
| 36 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.44096663 |
| 37 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.43583156 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.43115902 |
| 39 | * BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.39027711 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36620088 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33846786 |
| 42 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.32770841 |
| 43 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.31708222 |
| 44 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30965098 |
| 45 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30965098 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30953684 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30718212 |
| 48 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30569760 |
| 49 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.30304298 |
| 50 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28798442 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27851165 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27636645 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25149551 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24615554 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21574620 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.21151368 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18152409 |
| 58 | JUN_21703547_ChIP-Seq_K562_Human | 1.15543700 |
| 59 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.14927554 |
| 60 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14391119 |
| 61 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.14269579 |
| 62 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13387948 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.13330550 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12306386 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12061865 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09611786 |
| 67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08956373 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.07759880 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05482352 |
| 70 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04887933 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04132876 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03990870 |
| 73 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02063667 |
| 74 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.01041545 |
| 75 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00767284 |
| 76 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00737467 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97813605 |
| 78 | * TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97645759 |
| 79 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.96967561 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96254504 |
| 81 | * P300_27268052_Chip-Seq_Bcells_Human | 0.96163733 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95626779 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95308866 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95172913 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94292553 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93903057 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93782294 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93414183 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91840284 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91754245 |
| 91 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.90996650 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89626290 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89626290 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89138680 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88201541 |
| 96 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87446734 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87431185 |
| 98 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87132867 |
| 99 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86845331 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85767749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.35207398 |
| 2 | MP0003646_muscle_fatigue | 5.37171510 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.16739124 |
| 4 | MP0005167_abnormal_blood-brain_barrier | 3.82144204 |
| 5 | MP0008004_abnormal_stomach_pH | 3.06967747 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.91821549 |
| 7 | MP0004147_increased_porphyrin_level | 2.72398312 |
| 8 | MP0008872_abnormal_physiological_respon | 2.65258876 |
| 9 | MP0004130_abnormal_muscle_cell | 2.64511079 |
| 10 | MP0004381_abnormal_hair_follicle | 2.60782632 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.50295020 |
| 12 | MP0004043_abnormal_pH_regulation | 2.48806062 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.39403292 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.32022575 |
| 15 | MP0001919_abnormal_reproductive_system | 2.22175830 |
| 16 | MP0002160_abnormal_reproductive_system | 2.19041540 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10829841 |
| 18 | MP0001873_stomach_inflammation | 2.05259669 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.01228657 |
| 20 | MP0004858_abnormal_nervous_system | 1.95129388 |
| 21 | MP0005410_abnormal_fertilization | 1.87708862 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.85368633 |
| 23 | MP0000372_irregular_coat_pigmentation | 1.74089740 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.73183584 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.68837527 |
| 26 | MP0003136_yellow_coat_color | 1.67468726 |
| 27 | MP0005389_reproductive_system_phenotype | 1.63887360 |
| 28 | MP0003329_amyloid_beta_deposits | 1.52768984 |
| 29 | MP0005647_abnormal_sex_gland | 1.52214301 |
| 30 | MP0002163_abnormal_gland_morphology | 1.50664264 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.42104653 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.39142658 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.36716420 |
| 34 | MP0001664_abnormal_digestion | 1.33937845 |
| 35 | MP0004484_altered_response_of | 1.29838465 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.29095594 |
| 37 | MP0005266_abnormal_metabolism | 1.27659062 |
| 38 | MP0006054_spinal_hemorrhage | 1.26893120 |
| 39 | MP0003718_maternal_effect | 1.26337879 |
| 40 | MP0004883_abnormal_blood_vessel | 1.26322115 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.25343223 |
| 42 | MP0003045_fibrosis | 1.23418705 |
| 43 | MP0001790_abnormal_immune_system | 1.20493269 |
| 44 | MP0005387_immune_system_phenotype | 1.20493269 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.20106169 |
| 46 | MP0004233_abnormal_muscle_weight | 1.19315674 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.15305374 |
| 48 | MP0005365_abnormal_bile_salt | 1.14816015 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.10730891 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.10593635 |
| 51 | MP0002210_abnormal_sex_determination | 1.03763929 |
| 52 | MP0000230_abnormal_systemic_arterial | 1.03210519 |
| 53 | MP0009697_abnormal_copulation | 1.02434552 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.00417990 |
| 55 | MP0008877_abnormal_DNA_methylation | 0.99874287 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 0.97995333 |
| 57 | MP0000858_altered_metastatic_potential | 0.96830603 |
| 58 | MP0002132_abnormal_respiratory_system | 0.96250814 |
| 59 | MP0003693_abnormal_embryo_hatching | 0.94698049 |
| 60 | MP0005360_urolithiasis | 0.94374287 |
| 61 | MP0003638_abnormal_response/metabolism_ | 0.91786602 |
| 62 | MP0001663_abnormal_digestive_system | 0.89549195 |
| 63 | MP0003698_abnormal_male_reproductive | 0.88124837 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.85083651 |
| 65 | MP0003186_abnormal_redox_activity | 0.85023695 |
| 66 | MP0005646_abnormal_pituitary_gland | 0.83633040 |
| 67 | MP0000470_abnormal_stomach_morphology | 0.82024372 |
| 68 | MP0003195_calcinosis | 0.81228453 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 0.80647144 |
| 70 | MP0005448_abnormal_energy_balance | 0.79629631 |
| 71 | MP0008932_abnormal_embryonic_tissue | 0.79320886 |
| 72 | MP0009763_increased_sensitivity_to | 0.74171061 |
| 73 | MP0010307_abnormal_tumor_latency | 0.73705718 |
| 74 | MP0004957_abnormal_blastocyst_morpholog | 0.72855362 |
| 75 | MP0009764_decreased_sensitivity_to | 0.72417185 |
| 76 | MP0001929_abnormal_gametogenesis | 0.71140431 |
| 77 | MP0003879_abnormal_hair_cell | 0.69807610 |
| 78 | MP0001800_abnormal_humoral_immune | 0.68631440 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.68510250 |
| 80 | MP0001968_abnormal_touch/_nociception | 0.68164695 |
| 81 | MP0009745_abnormal_behavioral_response | 0.66206328 |
| 82 | MP0002398_abnormal_bone_marrow | 0.66169284 |
| 83 | MP0003724_increased_susceptibility_to | 0.65981481 |
| 84 | MP0008058_abnormal_DNA_repair | 0.64980613 |
| 85 | MP0000049_abnormal_middle_ear | 0.64708819 |
| 86 | MP0004142_abnormal_muscle_tone | 0.64466382 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.63868326 |
| 88 | MP0004510_myositis | 0.63833039 |
| 89 | MP0000747_muscle_weakness | 0.62812715 |
| 90 | MP0002723_abnormal_immune_serum | 0.61878075 |
| 91 | MP0001145_abnormal_male_reproductive | 0.61481550 |
| 92 | MP0002452_abnormal_antigen_presenting | 0.59807266 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.58301589 |
| 94 | MP0000653_abnormal_sex_gland | 0.57845499 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.57399490 |
| 96 | MP0008057_abnormal_DNA_replication | 0.57271820 |
| 97 | MP0000343_altered_response_to | 0.57132885 |
| 98 | MP0005671_abnormal_response_to | 0.56712760 |
| 99 | MP0003252_abnormal_bile_duct | 0.56502118 |
| 100 | MP0004134_abnormal_chest_morphology | 0.55327180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 8.96545326 |
| 2 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 7.60413087 |
| 3 | Hypoplasia of the fovea (HP:0007750) | 7.60413087 |
| 4 | Bilateral microphthalmos (HP:0007633) | 6.69564480 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 6.41305744 |
| 6 | Abnormality of the fovea (HP:0000493) | 6.07313812 |
| 7 | Prolonged bleeding time (HP:0003010) | 5.50505555 |
| 8 | Aplasia cutis congenita (HP:0001057) | 5.44831262 |
| 9 | Menorrhagia (HP:0000132) | 5.20209193 |
| 10 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.87947224 |
| 11 | Fused cervical vertebrae (HP:0002949) | 4.77816412 |
| 12 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.55706070 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 4.45855102 |
| 14 | Increased mean platelet volume (HP:0011877) | 4.28654633 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.27913078 |
| 16 | Abnormality of the right ventricle (HP:0001707) | 4.25786607 |
| 17 | Petechiae (HP:0000967) | 4.20537122 |
| 18 | Abnormality of transition element cation homeostasis (HP:0011030) | 4.17015961 |
| 19 | Abnormality of the parietal bone (HP:0002696) | 4.00384611 |
| 20 | Abnormal platelet volume (HP:0011876) | 3.95007805 |
| 21 | Widely patent fontanelles and sutures (HP:0004492) | 3.81493904 |
| 22 | Progressive inability to walk (HP:0002505) | 3.70457531 |
| 23 | Purpura (HP:0000979) | 3.63168487 |
| 24 | Mixed hearing impairment (HP:0000410) | 3.41925214 |
| 25 | Epistaxis (HP:0000421) | 3.23233761 |
| 26 | Abnormality of iron homeostasis (HP:0011031) | 3.21580229 |
| 27 | Lissencephaly (HP:0001339) | 3.09612837 |
| 28 | Concave nail (HP:0001598) | 3.00484443 |
| 29 | CNS hypomyelination (HP:0003429) | 2.99305150 |
| 30 | Decreased central vision (HP:0007663) | 2.94321055 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.87896321 |
| 32 | Lower limb hyperreflexia (HP:0002395) | 2.87602371 |
| 33 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.86633596 |
| 34 | Abnormal platelet function (HP:0011869) | 2.77064781 |
| 35 | Impaired platelet aggregation (HP:0003540) | 2.77064781 |
| 36 | Central scotoma (HP:0000603) | 2.62775693 |
| 37 | Poikilocytosis (HP:0004447) | 2.53280478 |
| 38 | Inability to walk (HP:0002540) | 2.50467711 |
| 39 | Posterior subcapsular cataract (HP:0007787) | 2.40193600 |
| 40 | Gingival bleeding (HP:0000225) | 2.39923128 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36483485 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34153480 |
| 43 | Hip dysplasia (HP:0001385) | 2.31497146 |
| 44 | Increased serum ferritin (HP:0003281) | 2.29864467 |
| 45 | Stomatitis (HP:0010280) | 2.29249499 |
| 46 | Sensorimotor neuropathy (HP:0007141) | 2.15669704 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.14323477 |
| 48 | Hyperalaninemia (HP:0003348) | 2.14323477 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14323477 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.13646667 |
| 51 | Vertebral fusion (HP:0002948) | 2.12644302 |
| 52 | Brushfield spots (HP:0001088) | 2.12003528 |
| 53 | Arthropathy (HP:0003040) | 2.08201276 |
| 54 | Large eyes (HP:0001090) | 2.08028683 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06095084 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.05144965 |
| 57 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.01071792 |
| 58 | Acanthocytosis (HP:0001927) | 2.00347897 |
| 59 | Ulnar deviation of the wrist (HP:0003049) | 1.99504452 |
| 60 | Wide cranial sutures (HP:0010537) | 1.98227720 |
| 61 | Tinnitus (HP:0000360) | 1.96634727 |
| 62 | Cerebral palsy (HP:0100021) | 1.95855865 |
| 63 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.95682823 |
| 64 | Tubular atrophy (HP:0000092) | 1.95576411 |
| 65 | Metabolic alkalosis (HP:0200114) | 1.91113704 |
| 66 | Clitoromegaly (HP:0000057) | 1.90552869 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.90303358 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88612519 |
| 69 | Birth length less than 3rd percentile (HP:0003561) | 1.87797452 |
| 70 | Tetraplegia (HP:0002445) | 1.87549131 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 1.85741900 |
| 72 | Severe muscular hypotonia (HP:0006829) | 1.82711218 |
| 73 | Hyperthyroidism (HP:0000836) | 1.80235823 |
| 74 | Constricted visual fields (HP:0001133) | 1.80110405 |
| 75 | Bulbous nose (HP:0000414) | 1.78564988 |
| 76 | Renal tubular acidosis (HP:0001947) | 1.77922152 |
| 77 | Hypoplasia of the uterus (HP:0000013) | 1.77409925 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 1.76055045 |
| 79 | Hydroxyprolinuria (HP:0003080) | 1.76055045 |
| 80 | Sprengel anomaly (HP:0000912) | 1.75361097 |
| 81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.75340591 |
| 82 | Joint swelling (HP:0001386) | 1.70861187 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 1.70747283 |
| 84 | Hyperglycinuria (HP:0003108) | 1.70355080 |
| 85 | Increased IgM level (HP:0003496) | 1.70012912 |
| 86 | Xanthomatosis (HP:0000991) | 1.66051703 |
| 87 | Decreased circulating renin level (HP:0003351) | 1.63693774 |
| 88 | Premature skin wrinkling (HP:0100678) | 1.61233311 |
| 89 | Prominent nose (HP:0000448) | 1.60413283 |
| 90 | Partial agenesis of the corpus callosum (HP:0001338) | 1.59478129 |
| 91 | Ventricular fibrillation (HP:0001663) | 1.58716267 |
| 92 | Abnormality of the renal cortex (HP:0011035) | 1.57786739 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 1.57497028 |
| 94 | Conical tooth (HP:0000698) | 1.56771541 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 1.56764217 |
| 96 | Triphalangeal thumb (HP:0001199) | 1.56116174 |
| 97 | Duplicated collecting system (HP:0000081) | 1.53879499 |
| 98 | Intrahepatic cholestasis (HP:0001406) | 1.51415751 |
| 99 | Attenuation of retinal blood vessels (HP:0007843) | 1.50018998 |
| 100 | Renal agenesis (HP:0000104) | 1.49612013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 9.77673413 |
| 2 | BMPR2 | 5.55181648 |
| 3 | TLK1 | 4.27547942 |
| 4 | SIK3 | 3.67949692 |
| 5 | SIK2 | 3.31214531 |
| 6 | PINK1 | 3.13025904 |
| 7 | TAOK3 | 2.26721305 |
| 8 | SIK1 | 2.17174637 |
| 9 | NEK2 | 2.16629854 |
| 10 | MST4 | 2.08943677 |
| 11 | ADRBK2 | 2.03874939 |
| 12 | MAP3K7 | 2.01489757 |
| 13 | ERBB2 | 1.80120038 |
| 14 | STK3 | 1.75596342 |
| 15 | BTK | 1.73596520 |
| 16 | MARK3 | 1.58698271 |
| 17 | MAP3K11 | 1.55054509 |
| 18 | ICK | 1.53281314 |
| 19 | STK11 | 1.44244594 |
| 20 | TEC | 1.43919147 |
| 21 | EIF2AK1 | 1.34177751 |
| 22 | BMX | 1.27834686 |
| 23 | ACVR1B | 1.23627621 |
| 24 | EEF2K | 1.17392144 |
| 25 | MAPKAPK3 | 1.15507252 |
| 26 | DAPK2 | 1.15186681 |
| 27 | SYK | 1.09905674 |
| 28 | TIE1 | 1.09141734 |
| 29 | PTK2B | 1.05035435 |
| 30 | MELK | 0.96247104 |
| 31 | MAPKAPK5 | 0.91524378 |
| 32 | ILK | 0.90363739 |
| 33 | IRAK1 | 0.85387718 |
| 34 | PRKAA2 | 0.75342041 |
| 35 | FLT3 | 0.73657736 |
| 36 | PRKAA1 | 0.72159767 |
| 37 | MAP2K1 | 0.70109173 |
| 38 | NUAK1 | 0.69784022 |
| 39 | FRK | 0.66298852 |
| 40 | TRPM7 | 0.64990809 |
| 41 | CAMK1 | 0.64720655 |
| 42 | CHEK2 | 0.63743570 |
| 43 | PRKCI | 0.61165831 |
| 44 | PIK3CG | 0.58978406 |
| 45 | BCR | 0.58869225 |
| 46 | TXK | 0.55075841 |
| 47 | MATK | 0.54501123 |
| 48 | MAPK13 | 0.53531083 |
| 49 | MYLK | 0.51965629 |
| 50 | JAK3 | 0.49831619 |
| 51 | GRK5 | 0.49148000 |
| 52 | PLK4 | 0.49116007 |
| 53 | MAP3K5 | 0.46110797 |
| 54 | STK38 | 0.45275573 |
| 55 | ZAK | 0.44884989 |
| 56 | PAK1 | 0.44121662 |
| 57 | ADRBK1 | 0.43171624 |
| 58 | BRSK2 | 0.42719488 |
| 59 | DAPK1 | 0.40977496 |
| 60 | PDPK1 | 0.38886762 |
| 61 | PRKACG | 0.36491097 |
| 62 | PKN1 | 0.35669284 |
| 63 | HCK | 0.34283080 |
| 64 | CAMK4 | 0.33962166 |
| 65 | HIPK2 | 0.33558272 |
| 66 | GRK1 | 0.32060860 |
| 67 | PRKCG | 0.31885425 |
| 68 | MAP3K1 | 0.30842190 |
| 69 | ZAP70 | 0.30743519 |
| 70 | BMPR1B | 0.30602867 |
| 71 | TNK2 | 0.28628116 |
| 72 | WNK4 | 0.26689145 |
| 73 | CDC42BPA | 0.26611084 |
| 74 | ATR | 0.26284486 |
| 75 | PDK1 | 0.26164523 |
| 76 | MAP3K2 | 0.25021948 |
| 77 | MAPK12 | 0.24946800 |
| 78 | PRKCZ | 0.23144764 |
| 79 | PRKCA | 0.22891720 |
| 80 | CDK12 | 0.22505208 |
| 81 | RPS6KA6 | 0.21679460 |
| 82 | RPS6KA5 | 0.20564605 |
| 83 | ITK | 0.20161206 |
| 84 | TTK | 0.17707008 |
| 85 | PRKCB | 0.16752656 |
| 86 | MAP3K3 | 0.16118035 |
| 87 | RET | 0.14992443 |
| 88 | KSR2 | 0.14861489 |
| 89 | MAPK4 | 0.14581339 |
| 90 | CDK4 | 0.14226777 |
| 91 | PIK3CA | 0.13818921 |
| 92 | IGF1R | 0.13484123 |
| 93 | JAK2 | 0.11611515 |
| 94 | MAPK10 | 0.11158912 |
| 95 | PLK1 | 0.10807067 |
| 96 | CSNK1D | 0.10298039 |
| 97 | CAMK2A | 0.10263348 |
| 98 | IKBKB | 0.10163878 |
| 99 | MAPK11 | 0.10137460 |
| 100 | PAK6 | 0.09440983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Olfactory transduction_Homo sapiens_hsa04740 | 3.79613490 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.63254180 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.22605799 |
| 4 | Platelet activation_Homo sapiens_hsa04611 | 2.84154290 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.63881437 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.41794265 |
| 7 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 2.36914633 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.35647021 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.14722437 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.13588679 |
| 11 | Long-term depression_Homo sapiens_hsa04730 | 2.00062010 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.91746890 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.91730490 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.91185151 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.83944794 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83321472 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.75599509 |
| 18 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.71543507 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.51623873 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50551127 |
| 21 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.48225858 |
| 22 | Alcoholism_Homo sapiens_hsa05034 | 1.36739629 |
| 23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.35079756 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.31694357 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.29051124 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24648565 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19469644 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15167700 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.15100065 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13195938 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13131639 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12236115 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.12001992 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10935125 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09737311 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00134361 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94184209 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93665374 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 0.90477340 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90150999 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89686910 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87915168 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87297046 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86368959 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82393300 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82170374 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82125244 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81440946 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.81344204 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81254938 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80122912 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78433604 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77949071 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76165433 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72654249 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71815580 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71652793 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70158158 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.68543749 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.68421281 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67261139 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64265694 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61076088 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60996678 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59933869 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58601105 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58296461 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57585364 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57542565 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56996615 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56035606 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51953306 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49306673 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49056540 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48928370 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48143877 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47000165 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46379535 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45580313 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44133012 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43691594 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42632966 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42306053 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42124982 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42086991 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41341929 |
| 87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39181517 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39124456 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.38936860 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36036281 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35243561 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34543601 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34033023 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34011353 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.33523853 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33214136 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32387607 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30512226 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29144364 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28549503 |

